Location History:
- Rockville, MD (US) (2006)
- Chicago, IL (US) (2010)
- Brookfield, CT (US) (2013)
- Bethesda, MD (US) (2007 - 2017)
Company Filing History:
11 out of 19 
1 out of 163 
1 out of 1,536 
Years Active: 2006-2017
Title: Innovations in Cancer Treatment by Robert Michael Lorence
Introduction
Robert Michael Lorence is a prominent inventor based in Bethesda, MD, known for his significant contributions to cancer treatment. With a total of 12 patents to his name, Lorence has focused on innovative methods that utilize viruses and camptothecins to combat neoplasms in mammalian subjects. His work has the potential to revolutionize cancer therapies and improve patient outcomes.
Latest Patents
Among his latest patents, Lorence has developed a method for cancer treatment using viruses and camptothecins. This method involves treating mammalian subjects with a combination of a virus, such as Newcastle disease virus or measles virus, and a camptothecin compound like irinotecan or topotecan. Additionally, his patent includes the administration of a monoclonal antibody against the epidermal growth factor receptor, such as cetuximab. Another notable patent focuses on an EGFR-directed combination treatment for non-small cell lung cancer. This method involves administering an irreversible tyrosine kinase inhibitor (TKI) in a continuous regimen, along with a monoclonal antibody, to effectively treat patients suffering from cancers driven by deregulated Human Epidermal Growth Factor Receptor.
Career Highlights
Throughout his career, Lorence has worked with various organizations, including Wellstat Biologics Corporation and the University of Ottawa. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in cancer treatment.
Collaborations
Some of Lorence's notable coworkers include Michael Scot Roberts and William S Groene. Their collaborative efforts have contributed to the advancement of innovative cancer therapies.
Conclusion
Robert Michael Lorence's work in cancer treatment showcases the importance of innovation in the medical field. His patents reflect a commitment to improving therapeutic options for patients battling cancer. The advancements he has made in utilizing viruses and camptothecins highlight the potential for new treatment methodologies that could change the landscape of oncology.